Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management

the rationale and impact section on managing other conditions after discharge from hospital. Full details of the evidence and the committee's discussion are in evidence review Q: long-term medicines for reducing the risk of subsequent subarachnoid haemorrhage and evidence review R: long-term medication for managing the consequences of subarachnoid haemorrhage. Investigations to detect aneurysms in relatives 1.4.15 Explain to people (and their families if appropriate) who have had an aneurysmal subarachnoid haemorrhage and are concerned about possible aneurysms in their relatives that: • routine testing to check for aneurysms in relatives has not been shown to save lives or prevent aneurysmal subarachnoid haemorrhages • testing for relatives is based on an assessment of the relative's own risk • testing is usually limited to people with at least 2 first-degree relatives (father, mother, sister or brother) who have had an aneurysmal subarachnoid haemorrhage. Tell people where they can find more information about testing for relatives, such as the NHS webpage on diagnosis of brain aneurysm. For a short explanation of why the committee made this recommendation and how it might affect practice, see the rationale and impact section on investigations to detect aneurysms in relatives. Full details of the evidence and
